Hey@Access2020 thanks for your honest thoughts and transparency. I also point out that when BCC provided their original arbitration timeline I got 'shutdown' by quite a few people stating that my negative sentiment around delays was unrealistic, and that the process is not going to encounter delays, as per the below example:
Another note: In the event of Zoleo being sold to RP - it is unlikely that they will price the sale of benefit to BCC to be a +300% of the current SP. Thus to even to get back to the breakeven of the SP for many/most holders is not going to be feasible, nor is it likely that BCC will even return to the SP of the pre-Zoleo and pre-arbitration announcement (~0.260-0.300 trading range).
It appears that in either of the outcomes the LTHs will be the losers, unless you have been averaging down over the past few months, which would be questionable considering how much risk is currently on the table.
If Zoleo is sold to BCC...well...the dilutionary tornado of debt and equity to fund that will really consolidate the losses for the LTHs. So either way for us the LTHs - there is no pleasant way out, time to pray that the offer goes over our average buy-in prices so that we can all go our separate ways.
Sadly though, one thing is clear and it is clear from Access's rhetoric as well - BCC's management has lost the trust of the shareholders as they continuously demonstrate lack of regard for the market forces that is making the LTHs progressively poorer (via SP decline). Making matters worse, we are paying this board 10-15% of our MC per annum for that...that is just straight up insulting.
Add to My Watchlist
What is My Watchlist?
